Corcept Therapeutics Incorporated
Net Cash Flow Breakdown
Total Cash from Operations: $203.4M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $2.2M | 1.1% |
| Other Investing | $168.8M | 83.0% |
| Stock Repurchases | $15.7M | 7.7% |
| Other Financing | $11.6M | 5.7% |
| Working Capital | $5.1M | 2.5% |
| Net Cash Flow | $0 | 0.0% |